Zobrazeno 1 - 10
of 17
pro vyhledávání: '"F A Klok"'
Autor:
M Cherenko, N M Appelman-Dijkstra, A L Priego Zurita, N R Biermasz, O M Dekkers, F A Klok, N Reisch, A Aulinas, B Biagetti, S Cannavo, L Canu, M Detomas, F Devuyst, H Falhammar, R A Feelders, F Ferrau, F Gatto, C Grasselli, P van Houten, C Hoybye, A M Isidori, A Kyrilli, P Loli, D Maiter, E Nowak, R Pivonello, O Ragnarsson, R V Steenaard, N Unger, A van de Ven, S M Webb, D Yeste, S F Ahmed, A M Pereira
Publikováno v:
Endocrine Connections, Vol 13, Iss 6, Pp 1-10 (2024)
Background: Patients with Cushing syndrome (CS) are at increased risk of venous thromboembolism (VTE). Objective: The aim was to evaluate the current management of new cases of CS with a focus on VTE and thromboprophylaxis. Design and methods: A sur
Externí odkaz:
https://doaj.org/article/0d6f12c986c64a9489f0b3026c083007
Autor:
F. M. van Haalen, M. Kaya, I. C. M. Pelsma, O. M. Dekkers, N. R. Biermasz, S. C. Cannegieter, M. V. Huisman, B. J. M. van Vlijmen, R. A. Feelders, F. A. Klok, A. M. Pereira, Endo-ERN Cushing and Thrombosis study group
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background Cushing’s syndrome (CS) is associated with an hypercoagulable state and an increased risk of venous thromboembolism (VTE). Evidence-based guidelines on thromboprophylaxis strategies in patients with CS are currently lacking. We
Externí odkaz:
https://doaj.org/article/2cca4a39f38c4dd2b220a26962101ae9
Autor:
Elia Asady, Waleed Ghanima, Lars‐Petter Jelsness‐Jorgensen, F. A. Klok, Susan R. Kahn, Hilde Stromme, Hilde S. Wik
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Abstract To improve the quality and accuracy of the patient‐reported outcome measures that assess health‐related quality of life (HRQoL), guidelines have been developed to standardize the development and validation process. Considering the increa
Externí odkaz:
https://doaj.org/article/544f860a48b54db4a4343dbf68173549
Autor:
G.-J. Geersing, N. Kraaijpoel, H. R. Büller, S. van Doorn, N. van Es, G. Le Gal, M. V. Huisman, C. Kearon, J. A. Kline, K. G. M. Moons, M. Miniati, M. Righini, P.-M. Roy, S. J. van der Wall, P. S. Wells, F. A. Klok
Publikováno v:
Diagnostic and Prognostic Research, Vol 2, Iss 1, Pp 1-8 (2018)
Abstract Background Diagnosing pulmonary embolism in suspected patients is notoriously difficult as signs and symptoms are non-specific. Different diagnostic strategies have been developed, usually combining clinical probability assessment with D-dim
Externí odkaz:
https://doaj.org/article/548c3032d6684eb68f505282dcd9a05e
Autor:
М. Delcroix, А. Torbicki, D. Gopalan, O. Sitbon, F. A. Klok, I. Lang, D. Jenkins, N. H. Kim, M. Humbert, X. Jais, A. V. Noordegraaf, J. Pepke-Zaba, P. Brénot, P. Dorfmuller, E. Fadel, H.-A. Ghofrani, M. M. Hoeper, P. Jansa, M. Madani, H. Matsubara, T. Ogo, A. D’Armini, N. Galie, B. Meyer, P. Corkery, G. Meszaros, E. Mayer, G. Simonneau
Publikováno v:
PULMONOLOGIYA. 32:13-52
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary arteries by fibrotic intravascular material, in combination with a secondary micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37553a1e032b7208dee4a1ff38f95df8
https://doi.org/10.18093/0869-0189-2022-32-1-13-52
https://doi.org/10.18093/0869-0189-2022-32-1-13-52
Autor:
K Bonnesen, F A Klok, M J Andersen, A Andersen, J E Nielsen-Kudsk, S Mellemkjaer, H T Sorensen, M Schmidt
Publikováno v:
European Heart Journal. 43
Background One of the ultimate long-term complications of venous thromboembolism (VTE) is chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a condition defined as an increased mean pulmonary arterial pressure of at least 25 mmHg at rest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe83d19336ff76d9463ce673d46be302
https://doi.org/10.1093/eurheartj/ehac544.1868
https://doi.org/10.1093/eurheartj/ehac544.1868
Autor:
I Farmakis, L Valerio, A C Mavromanoli, B Bikdeli, J M Connors, G Giannakoulas, S Z Goldhaber, L Hobohm, B J Hunt, K Keller, F A Klok, A C Spyropoulos, N Kucher, S Konstantinides, S Barco
Publikováno v:
European Heart Journal. 43
Background The COVID-19 pandemic caused a large number of excess deaths. COVID-19 emerged as a prothrombotic disease often complicated by pulmonary embolism (PE). In light of this, we hypothesized that PE-related mortality rates (stable before the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae15f0a021dd94d204840edf2210c6c6
https://doi.org/10.1093/eurheartj/ehac544.1869
https://doi.org/10.1093/eurheartj/ehac544.1869
Autor:
F A Klok, B Siegerink
Publikováno v:
The Lancet. 401:995
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5803a6229a3852c79e689b94037f62a
https://doi.org/10.1016/s0140-6736(23)00137-x
https://doi.org/10.1016/s0140-6736(23)00137-x
Publikováno v:
European Heart Journal. 42
Background Little is known about the extent to which an active cancer diagnosis increases bleeding and thromboembolic risks in atrial fibrillation (AF) patients. Data on major bleeding rates per antithrombotic management strategy are lacking in AF pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90b6546a87420b5799129edee21fcea4
https://doi.org/10.1093/eurheartj/ehab724.2869
https://doi.org/10.1093/eurheartj/ehab724.2869
Publikováno v:
European Heart Journal. 42
Aims This survey conducted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and ESC Working Group on Pulmonary Circulation & Right Ventricular Functioncollected information on current practices in catheter-directed tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdc5023155fe2df26411cd22366db4ff
https://doi.org/10.1093/eurheartj/ehab724.1927
https://doi.org/10.1093/eurheartj/ehab724.1927